N, M., JC, M., JR, J., AM, D., CD, C., Y, M., . . . L, W. (2024). Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics. Cancers, 16(19), . https://doi.org/10.3390/cancers16193262
Chicago Style (17th ed.) CitationN, Mavingire, Moore JC, Johnson JR, Dwead AM, Cropp CD, Mechref Y, Kobeissy F, Rais-Bahrami S, and Woods-Burnham L. "Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics." Cancers 16, no. 19 (2024). https://doi.org/10.3390/cancers16193262.
MLA (9th ed.) CitationN, Mavingire, et al. "Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics." Cancers, vol. 16, no. 19, 2024, https://doi.org/10.3390/cancers16193262.
Warning: These citations may not always be 100% accurate.